In the last trading session, 3.52 million Absci Corp (NASDAQ:ABSI) shares changed hands as the company’s beta touched 2.08. With the company’s per share price at $2.77 changed hands at -$0.11 or -3.82% during last session, the market valuation stood at $353.34M. ABSI’s last price was a discount, traded about -128.52% off its 52-week high of $6.33. The share price had its 52-week low at $2.01, which suggests the last value was 27.44% up since then.
Analysts gave the Absci Corp (ABSI) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended ABSI as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight.
Absci Corp (NASDAQ:ABSI) trade information
Instantly ABSI was in red as seen at the end of in last trading. With action -5.46%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 5.73%, with the 5-day performance at -5.46% in the red. However, in the 30-day time frame, Absci Corp (NASDAQ:ABSI) is -10.36% down.
The consensus price target for the stock as assigned by Wall Street analysts is 6, meaning bulls need an upside of 53.83% from its current market value. According to analyst projections, ABSI’s forecast low is 6 with 6 as the target high. To hit the forecast high, the stock’s price needs a -116.61% plunge from its current level, while the stock would need to soar -116.61% for it to hit the projected low.
Absci Corp (ABSI) estimates and forecasts
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -29.30%. The 2025 estimates are for Absci Corp earnings to increase by 7.62%, but the outlook for the next 5-year period is at 3.68% per year.
Absci Corp (NASDAQ:ABSI)’s Major holders
REDMILE GROUP, LLC holds the second largest percentage of outstanding shares, with 7.3081% or 8.25 million shares worth $25.42 million as of 2024-06-30.
Among Mutual Funds, the top two as of Apr 30, 2025 were ARK ETF Trust-ARK Genomic Revolution ETF and Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund. With 9.76 shares estimated at $27.02 million under it, the former controlled 7.65% of total outstanding shares. On the other hand, Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund held about 4.25% of the shares, roughly 5.42 shares worth around $15.0 million.
